David Matousek
Keine laufenden Positionen mehr
Profil
David Matousek held several positions in various firms.
He was a Director at Kermode Resources Ltd., Director & Head-Investor Relations at Playfair Mining Ltd., Director-Investor Relations at CRH Medical Corp., President at Yankee Hat Minerals Ltd., Head-Corporate Communications & Investor Relations at Eagle Hill Exploration Corp., Senior Manager-Investor Relations & Communications at Zymeworks BC, Inc., and Manager-Investor Relations at Lupaka Gold Corp.
He obtained his undergraduate degree from Simon Fraser University.
Ehemalige bekannte Positionen von David Matousek
| Unternehmen | Position | Ende |
|---|---|---|
Eagle Hill Exploration Corp.
 Eagle Hill Exploration Corp. Other Metals/MineralsNon-Energy Minerals Eagle Hill Exploration Corp. is a mining exploration company, which focuses on exploration and development of the high-grade Windfall Lake Gold Deposit, located between Val-d'Or and Chibougamau in Quebec. The company was founded on July 21, 2006 and is headquartered in Vancouver, Canada. | Investor Relations Kontakt | 14.08.2013 |
Yankee Hat Minerals Ltd.
 Yankee Hat Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Yankee Hat Minerals Ltd. was a mineral exploration company, which engaged in the acquisition, exploration and development of precious metal properties. The company was founded on October 22, 1993 and was headquartered in Vancouver, Canada. | Präsident | 01.11.2012 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Investor Relations Kontakt | - |
| CRH MEDICAL CORPORATION | Investor Relations Kontakt | - |
| LUPAKA GOLD CORP. | Investor Relations Kontakt | - |
Ausbildung von David Matousek
| Simon Fraser University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PLAYFAIR MINING LTD. | Non-Energy Minerals |
| KERMODE RESOURCES LTD. | Non-Energy Minerals |
| LUPAKA GOLD CORP. | Non-Energy Minerals |
| Private Unternehmen | 4 |
|---|---|
Yankee Hat Minerals Ltd.
Yankee Hat Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Yankee Hat Minerals Ltd. was a mineral exploration company, which engaged in the acquisition, exploration and development of precious metal properties. The company was founded on October 22, 1993 and was headquartered in Vancouver, Canada. | Non-Energy Minerals |
Eagle Hill Exploration Corp.
Eagle Hill Exploration Corp. Other Metals/MineralsNon-Energy Minerals Eagle Hill Exploration Corp. is a mining exploration company, which focuses on exploration and development of the high-grade Windfall Lake Gold Deposit, located between Val-d'Or and Chibougamau in Quebec. The company was founded on July 21, 2006 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
CRH Medical Corp.
 CRH Medical Corp. Medical/Nursing ServicesHealth Services CRH Medical Corp. engages in the provision of gastroenterologists with services and products for the treatment of gastrointestinal diseases. It operates through the following business segments: Anesthesia Services, Product Sales, and Other. It also offers the CRH O'Regan System, which focuses on physician education, patient outcomes, and patient awareness. The Other segment covers the corporate activities. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
